Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1996-07-09
1998-11-10
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424458, 424459, 424462, 424468, 514963, A61K 958, A61K 922, A61K 914
Patent
active
058340238
ABSTRACT:
A once-a-day controlled release diltiazem formulation is described which includes:
(a) from 20 to 50% by weight of enteric polymeric membrane coated pellets comprising a polymer membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder; and a second layer which comprises a membrane comprising a pH dependent polymeric material; and
(b) from 50% to 80% by weight of delayed pulse polymeric membrane coated pellets comprising a polymeric membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder and a second layer which comprises a polymeric membrane which will substantially maintain its integrity in the varying pH conditions of the gastrointestinal tract but is permeable to diltiazem; and
(c) a unit dose containment system.
REFERENCES:
patent: 4891230 (1990-01-01), Geoghegan et al.
patent: 4894240 (1990-01-01), Geoghegan et al.
patent: 4917899 (1990-04-01), Geoghegan et al.
patent: 4963365 (1990-10-01), Samejima et al.
patent: 5002776 (1991-03-01), Geoghegan et al.
patent: 5051262 (1991-09-01), Panoz et al.
patent: 5112621 (1992-05-01), Stevens et al.
patent: 5137733 (1992-08-01), Noda et al.
patent: 5149542 (1992-09-01), Valducci
patent: 5229135 (1993-07-01), Philippon et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5288505 (1994-02-01), Deboeck et al.
patent: 5336504 (1994-08-01), Geoghegan et al.
patent: 5344657 (1994-09-01), Desmolin
patent: 5364620 (1994-11-01), Geoghegan et al.
patent: 5376384 (1994-12-01), Eichel et al.
patent: 5472710 (1995-12-01), Klokkers-Bethke et al.
patent: 5529790 (1996-06-01), Eichel et al.
Andrx Pharmaceuticals Inc.
Page Thurman K.
Spear James M.
LandOfFree
Diltiazem controlled release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diltiazem controlled release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diltiazem controlled release formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1514300